Herbal tablet aims to reverse liver scarring in fatty liver disease
NCT ID NCT07663643
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether Fuzheng Huayu tablets, a traditional Chinese herbal medicine, can reduce liver scarring in people with compensated cirrhosis caused by metabolic fatty liver disease. Participants are randomly assigned to receive either the herbal tablets or a placebo for 72 weeks. The main goal is to see if liver stiffness, measured by FibroScan, decreases by at least 20%.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Fuzheng Huayu Tablets (herbal medicine)
- What this could lead to
- If effective, this could offer a new treatment option to reduce liver scarring in people with fatty liver cirrhosis, potentially slowing disease progression.
- What could go wrong
- This is a Phase 4 study, but the herbal supplement may not prove better than placebo. Results depend on liver stiffness measurements, which are indirect markers of fibrosis.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.